ADVATE 250 IU, powder and solvent for solution for injection bottle, 2 ml
Active ingredients: Antihemophilic factor, human recombinant
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 2 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ADVATE 250 UI, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 250 UI - 1 flacon(s) en verre de 2 ml avec dispositif BAXJECTIII
- Marketing authorisation holder
- TAKEDA MANUFACTURING AUSTRIA (AUTRICHE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 Oct 2015
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68294455CIP75872029CIP133400958720291Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OCTOCOG ALFApoudre | 250 UI · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.